Clinical Trial Update: Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis

View source ↗

Summary

A completed clinical trial evaluating gene expression profiling in peripheral blood mononuclear cells to predict responsiveness to infliximab in rheumatoid arth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Rheumatoid Arthritis | Status: COMPLETED